Oklahoma City-based Integris Health recorded operating income of $104.4 million (2.8% operating margin) in fiscal 2026, up from an operating loss of $22.3 million (-0.7% margin) during the same period last year, according to its Nov. 17 financial report.
Six things to know:
1. Integris reported total operating revenue of $3.7 billion for the 12 months ended June 30, up from $3.3 billion during the same period last year. Net patient service revenue totaled $3.2 billion, up from $2.9 billion. Specialty pharmacy revenue totaled $166.4 million, up from $128.9 million, and other operating revenue totaled $378.2 million, up from $283.1 million.
2. Total operating expenses were $3.6 billion, up from $3.3 billion. Salaries and benefits totaled $1.7 billion, up from $1.5 billion, which Integris attributed to service line expansion and continued wage inflation. Supplies and other expenses totaled $1.6 billion, up from $1.5 billion, and specialty pharmacy supplies totaled $110.3 million, up from $81.3 million. Contract labor totaled $24.4 million, down from $29 million.
3. Integris’ fiscal 2026 results included $92.8 million in reimbursement revenue from FEMA, all of it recognized in the fourth quarter. Excluding that revenue, the system generated approximately $11.6 million in operating income.
4. Acute hospital discharges totaled 62,407, up from 58,835, and emergency room admissions totaled 45,709, up from 42,602. Medical group visits totaled 1.1 million, up from 1 million. Total surgeries totaled 104,474, down from 107,923, as outpatient surgeries declined. Commercial payers accounted for 30.7% of gross revenue, down from 32.1%, while Medicaid accounted for 16.2%, up from 15.4%.
5. Integris reported net income of $146.6 million in fiscal 2026, up from $12 million during the same period last year. Nonoperating income totaled $88.3 million, including $96.2 million in investment income.
6. Integris signed a definitive agreement Oct. 21 to join Oakland, Calif.-based Kaiser Permanente’s Risant Health. Risant will make at least $1.3 billion in capital available for facilities and other projects, a total that includes cash Integris generates itself as well as Risant funds, according to Kaiser’s Nov. 13 financial report. Risant will also guarantee up to $400 million for Integris’ transition and integration, including the first rollout of Risant’s value-based care platform, and make up to $200 million in additional growth capital available if Integris meets financial performance targets. The funding is available through Dec. 31 of the fourth anniversary year after the deal closes, which is expected in 2027, pending regulatory approval.